Autor/in Mahner, S 2 Sehouli, J Braicu, I 1 Cadron, I 1 Chekerov, R 1 Concin, N 1 Grimm, C 1 Harter, P 1 Hilpert, F 1 Hofstetter, G 1 Mustea, A 1 Ortmann, O 1 Runnebaum, I 1 Trillsch, F 1 Ulmer, H 1 Van Gorp, T 1 Wagner, U 1 du Bois, A 1 alle zeigenListe einklappen
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer Harter, P Mahner, S Hilpert, F Runnebaum, I Ortmann, O Mustea, A Sehouli, J 2013 - Forschungsinformationssystem des UKE
The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study Hofstetter, G Concin, N Braicu, I Chekerov, R Sehouli, J Cadron, I Van Gorp, T 2013 - Forschungsinformationssystem des UKE
